Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand

<p>Abstract</p> <p>Background</p> <p>Susceptibility testing of pyrazinamide (PZA) against <it>Mycobacterium tuberculosis </it>is difficult to perform because the acidity of culture medium that is required for drug activity also inhibits the growth of bacteri...

Full description

Bibliographic Details
Main Authors: Jonmalung Jirarut, Prammananan Therdsak, Leechawengwongs Manoon, Chaiprasert Angkana
Format: Article
Language:English
Published: BMC 2010-08-01
Series:BMC Microbiology
Online Access:http://www.biomedcentral.com/1471-2180/10/223
id doaj-32cf5f407c7643c19f05a9b8d4cf9fa4
record_format Article
spelling doaj-32cf5f407c7643c19f05a9b8d4cf9fa42020-11-24T23:28:19ZengBMCBMC Microbiology1471-21802010-08-0110122310.1186/1471-2180-10-223Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, ThailandJonmalung JirarutPrammananan TherdsakLeechawengwongs ManoonChaiprasert Angkana<p>Abstract</p> <p>Background</p> <p>Susceptibility testing of pyrazinamide (PZA) against <it>Mycobacterium tuberculosis </it>is difficult to perform because the acidity of culture medium that is required for drug activity also inhibits the growth of bacteria. In Thailand, very limited information has been generated on PZA resistance, particularly among multidrug-resistant tuberculosis (MDR-TB) isolated from Thailand. Only two studies on PZA susceptibility among Thai <it>M. tuberculosis </it>strains have been reported; one used a pyrazinamidase assay, and the other used the BACTEC 460 TB for PZA susceptibility testing. In this study, we determined the percentage of strains possessing pyrazinamide resistance among pan-susceptible <it>M. tuberculosis </it>and MDR-TB isolates by using the pyrazinamidase assay, BACTEC MGIT 960 PZA method and <it>pncA </it>sequencing, and assessed the correlation in the data generated using these methods. The type and frequency of mutations in <it>pncA </it>were also determined.</p> <p>Results</p> <p>Overall, 150 <it>M. tuberculosis </it>isolates, consisting of 50 susceptible and 100 MDR-TB isolates, were tested for PZA susceptibility by BACTEC MGIT 960 PZA, the pyrazinamidase assay and <it>pncA </it>sequencing. The study indicated PZA resistance in 6% and 49% of susceptible and MDR-TB isolates, respectively. In comparison to the BACTEC MGIT 960 PZA, the PZase assay showed 65.4% sensitivity and 100% specificity, whereas <it>pncA </it>sequencing showed 75% sensitivity and 89.8% specificity. Twenty-four mutation types were found in this study, with the most frequent mutation (16%) being His71Asp. Of these mutations, eight have not been previously described. The Ile31Ser and Ile31Thr mutations were found both in PZA susceptible and resistant isolates, suggesting that mutation of this codon might not play a role on PZA resistance.</p> <p>Conclusions</p> <p>Our findings suggest that phenotypic susceptibility testing is still essential for the detection of PZA resistance, especially for MDR-TB isolates. Some mutations were not associated with resistance and could lead to misinterpretation of the genotypic methods. This information could be helpful for clinicians in managing tuberculosis patients and frequencies, and the types of <it>pncA </it>mutations should offer baseline information on PZA resistance.</p> http://www.biomedcentral.com/1471-2180/10/223
collection DOAJ
language English
format Article
sources DOAJ
author Jonmalung Jirarut
Prammananan Therdsak
Leechawengwongs Manoon
Chaiprasert Angkana
spellingShingle Jonmalung Jirarut
Prammananan Therdsak
Leechawengwongs Manoon
Chaiprasert Angkana
Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
BMC Microbiology
author_facet Jonmalung Jirarut
Prammananan Therdsak
Leechawengwongs Manoon
Chaiprasert Angkana
author_sort Jonmalung Jirarut
title Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
title_short Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
title_full Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
title_fullStr Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
title_full_unstemmed Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
title_sort surveillance of pyrazinamide susceptibility among multidrug-resistant <it>mycobacterium tuberculosis </it>isolates from siriraj hospital, thailand
publisher BMC
series BMC Microbiology
issn 1471-2180
publishDate 2010-08-01
description <p>Abstract</p> <p>Background</p> <p>Susceptibility testing of pyrazinamide (PZA) against <it>Mycobacterium tuberculosis </it>is difficult to perform because the acidity of culture medium that is required for drug activity also inhibits the growth of bacteria. In Thailand, very limited information has been generated on PZA resistance, particularly among multidrug-resistant tuberculosis (MDR-TB) isolated from Thailand. Only two studies on PZA susceptibility among Thai <it>M. tuberculosis </it>strains have been reported; one used a pyrazinamidase assay, and the other used the BACTEC 460 TB for PZA susceptibility testing. In this study, we determined the percentage of strains possessing pyrazinamide resistance among pan-susceptible <it>M. tuberculosis </it>and MDR-TB isolates by using the pyrazinamidase assay, BACTEC MGIT 960 PZA method and <it>pncA </it>sequencing, and assessed the correlation in the data generated using these methods. The type and frequency of mutations in <it>pncA </it>were also determined.</p> <p>Results</p> <p>Overall, 150 <it>M. tuberculosis </it>isolates, consisting of 50 susceptible and 100 MDR-TB isolates, were tested for PZA susceptibility by BACTEC MGIT 960 PZA, the pyrazinamidase assay and <it>pncA </it>sequencing. The study indicated PZA resistance in 6% and 49% of susceptible and MDR-TB isolates, respectively. In comparison to the BACTEC MGIT 960 PZA, the PZase assay showed 65.4% sensitivity and 100% specificity, whereas <it>pncA </it>sequencing showed 75% sensitivity and 89.8% specificity. Twenty-four mutation types were found in this study, with the most frequent mutation (16%) being His71Asp. Of these mutations, eight have not been previously described. The Ile31Ser and Ile31Thr mutations were found both in PZA susceptible and resistant isolates, suggesting that mutation of this codon might not play a role on PZA resistance.</p> <p>Conclusions</p> <p>Our findings suggest that phenotypic susceptibility testing is still essential for the detection of PZA resistance, especially for MDR-TB isolates. Some mutations were not associated with resistance and could lead to misinterpretation of the genotypic methods. This information could be helpful for clinicians in managing tuberculosis patients and frequencies, and the types of <it>pncA </it>mutations should offer baseline information on PZA resistance.</p>
url http://www.biomedcentral.com/1471-2180/10/223
work_keys_str_mv AT jonmalungjirarut surveillanceofpyrazinamidesusceptibilityamongmultidrugresistantitmycobacteriumtuberculosisitisolatesfromsirirajhospitalthailand
AT prammananantherdsak surveillanceofpyrazinamidesusceptibilityamongmultidrugresistantitmycobacteriumtuberculosisitisolatesfromsirirajhospitalthailand
AT leechawengwongsmanoon surveillanceofpyrazinamidesusceptibilityamongmultidrugresistantitmycobacteriumtuberculosisitisolatesfromsirirajhospitalthailand
AT chaiprasertangkana surveillanceofpyrazinamidesusceptibilityamongmultidrugresistantitmycobacteriumtuberculosisitisolatesfromsirirajhospitalthailand
_version_ 1725549748066189312